AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank83
5Y CAGR-17.0%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-17.0%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 30.14% |
| 2024 | 21.66% |
| 2023 | -64.77% |
| 2022 | -95.89% |
| 2021 | -196.18% |
| 2020 | 76.55% |
| 2019 | 0.00% |